Detalhe da pesquisa
1.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
Am J Hematol
; 95(5): 503-509, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072687
2.
Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost.
Curr Stem Cell Res Ther
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584546
3.
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis.
Clin Lymphoma Myeloma Leuk
; 22(5): 297-304, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844892
4.
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients.
Leuk Lymphoma
; 61(8): 1885-1893, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306794
5.
Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression.
Leuk Lymphoma
; 63(3): 759-761, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076333